Ultragenyx and Mereo advance UX143 osteogenesis imperfecta study to final analysis
Go back to Ultragenyx and Mereo advance UX143 osteogenesis imperfecta study to final analysis| Mirenco, Inc. (NASDAQ: MREO) | Delayed: 0.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.32 | 52 Week High | $0.01 | |||
| Open | $0.32 | 52 Week Low | $0.00 | |||
| Day High | $0.32 | P/E | N/A | |||
| Day Low | $0.32 | EPS | $-0.02 | |||
| Volume | 61,567 | |||||
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 29.79 -0.43 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.22 | 52 Week High | $117.12 | |||
| Open | $29.16 | 52 Week Low | $46.52 | |||
| Day High | $30.07 | P/E | N/A | |||
| Day Low | $28.90 | EPS | $-1.97 | |||
| Volume | 151,987 | |||||
